ATE183394T1 - Verwendung von phosphorsäurediester-verbindungen zur unterdrückung von krebsmetastasen in der leber - Google Patents

Verwendung von phosphorsäurediester-verbindungen zur unterdrückung von krebsmetastasen in der leber

Info

Publication number
ATE183394T1
ATE183394T1 AT95302003T AT95302003T ATE183394T1 AT E183394 T1 ATE183394 T1 AT E183394T1 AT 95302003 T AT95302003 T AT 95302003T AT 95302003 T AT95302003 T AT 95302003T AT E183394 T1 ATE183394 T1 AT E183394T1
Authority
AT
Austria
Prior art keywords
liver
diester compounds
cancer metastases
suppress cancer
phosphoric diester
Prior art date
Application number
AT95302003T
Other languages
English (en)
Inventor
Tetsuya Toge
Toshihiro Hirai
Akihiro Yoshimoto
Kenichi Yoshida
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE183394T1 publication Critical patent/ATE183394T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95302003T 1994-03-29 1995-03-24 Verwendung von phosphorsäurediester-verbindungen zur unterdrückung von krebsmetastasen in der leber ATE183394T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5867194 1994-03-29
JP24016794 1994-10-04

Publications (1)

Publication Number Publication Date
ATE183394T1 true ATE183394T1 (de) 1999-09-15

Family

ID=26399697

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95302003T ATE183394T1 (de) 1994-03-29 1995-03-24 Verwendung von phosphorsäurediester-verbindungen zur unterdrückung von krebsmetastasen in der leber

Country Status (7)

Country Link
US (1) US5552389A (de)
EP (1) EP0674904B1 (de)
KR (1) KR950032257A (de)
AT (1) ATE183394T1 (de)
CA (1) CA2145229A1 (de)
DE (1) DE69511448T2 (de)
ES (1) ES2134409T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
AU2002303210A1 (en) 2001-04-06 2002-10-21 Cytorex Biosciences, Inc. Pharmacologically active strong acid solutions
AU2002317053B2 (en) 2001-07-27 2004-08-05 Vital Health Sciences Pty Ltd Dermal therapy using phosphate derivatives of electron transfer agents
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
CA2557354C (en) 2004-03-03 2013-05-07 Vital Health Sciences Pty Ltd. Alkaloid formulations
AU2006220247B2 (en) * 2005-03-03 2011-08-25 Vital Health Sciences Pty Ltd Compounds having anti-cancer properties
KR20070108383A (ko) * 2005-03-03 2007-11-09 바이탈 헬스 사이언시즈 피티와이 리미티드 지질 저하성 화합물
WO2006092024A1 (en) * 2005-03-03 2006-09-08 Vital Health Sciences Pty Ltd Compounds having anti-cancer properties
MX2007015949A (es) 2005-06-17 2008-03-07 Vital Health Sciences Pty Ltd Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos.
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
JP5806287B2 (ja) 2010-03-30 2015-11-10 フォスファジェニクス リミティド 経皮送達パッチ
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
MX383940B (es) 2015-12-09 2025-03-14 Phosphagenics Ltd Formulación farmacéutica que contiene tocol fosfato.
JP7198754B2 (ja) 2016-12-21 2023-01-04 アベーチョ バイオテクノロジー リミテッド 方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62145019A (ja) * 1985-12-19 1987-06-29 Senjiyu Seiyaku Kk 抗炎症剤
JPH02229168A (ja) * 1989-03-01 1990-09-11 Takeda Chem Ind Ltd ピラゾロン誘導体
JPH02229169A (ja) * 1989-03-01 1990-09-11 Takeda Chem Ind Ltd ピラゾロン誘導体

Also Published As

Publication number Publication date
DE69511448D1 (de) 1999-09-23
KR950032257A (ko) 1995-12-20
EP0674904B1 (de) 1999-08-18
EP0674904A1 (de) 1995-10-04
DE69511448T2 (de) 2000-04-27
CA2145229A1 (en) 1995-09-30
US5552389A (en) 1996-09-03
ES2134409T3 (es) 1999-10-01

Similar Documents

Publication Publication Date Title
DE69511448D1 (de) Verwendung von Phosphorsäurediester-Verbindungen zur Unterdrückung von Krebsmetastasen in der Leber
DE3070229D1 (en) Derivatives of 4-(methylphosphinyl)-2-oxobutanoic acid, herbicidal compositions containing them, and intermediates and methods for their production
FI852974A0 (fi) Nya n-hydroxylgruppen skyddande grupper och framstaellningsfoerfarande foer 3-acylamino-1-hydroxi-2-azetidinoner.
DE60332350D1 (de) Disazofarbstoffe und sie enthaltende tintenstrahldrucktinten
SE8302694L (sv) Immunomudulerande medel
ATE141508T1 (de) Zusammensetzung zur förderung des lipidmetabolismus
PT1384707E (pt) Ester 4-nitroxibutilico de naproxeno
FI860369A0 (fi) Imidazolderivat, deras framstaellning och anvaendning samt dessa derivat innehaollande farmaceutiska kompositioner.
DE3372364D1 (en) 1-carboxyalkanoylperhydroindole-2-carboxylic acids and derivatives
DE60002733D1 (de) Diester prodrugs von decahydroischinoline-3-carbonsäure
GR3006217T3 (de)
ES2186322T3 (es) Derivados de acido perfluor-n-alcanosulfonico.
ES2065994T3 (es) Beta-dicetonas substituidas.
TR200402776T4 (tr) Nöraminik asit bileşiğinin hidratları ve bunların kristal biçimleri.
DE69930842D1 (de) Kosmetische formulierungen enthaltend bis(triorganosilyl)hydrocarbonsäure-derivate
DE59810578D1 (de) Mischungen von langkettigen Phosphorsäurealkylestern
IN190321B (de)
ES8303434A1 (es) Procedimiento para la obtencion de amidas del ester de acido fosforico (fosfonico).
DE59808546D1 (de) Verwendung von fettsäureniedrigalkylestern in abbeizmitteln
ATE118500T1 (de) Phospholipidderivate.
EP0108547A3 (en) 1-bromoethyl ethyl carbonate and its use in the preparation of 1'-ethoxy-carbonyloxyethyl esters of penicillins and novel intermediates, methods for its preparation and 1-bromoethylchloroformate and 1-bromoethylbromoformate obtained as intermediates
ATE241976T1 (de) N,n'-bis (sulfonyl) hydrazine die als antineoplastische mittel nützlich sind
ATE44960T1 (de) Phosphorsaeureester.
ATE224398T1 (de) Phosphorsäureester
YU2994A (sh) Prolekovi antinflamatornih 3-acil-2-oksindol-1-karboksamida